IP Verse

Lindhofer, Horst, Dr. opposition analysis

COMPANY ANALYSIS

Latest patents of Lindhofer, Horst, Dr. opposed by its competitors

Patent:
EP3177645
Grant Date:
Feb 17, 2021
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Oppositions:
10

Competitors of Lindhofer, Horst, Dr.

ABBVIE INC.

BOEHRINGER INGELHEIM RCV GMBH & CO KG / BOEHRINGER INGELHEIM INTERNATIONAL GMBH

DR. H. ULRICH DORRIES

Want to track Lindhofer, Horst, Dr.?

Feel free to send us a message here and we will get back to you